PASITHEA THERAPEUTICS CORP. Disposal Group, Including Discontinued Operation, General and Administrative Expense
PASITHEA THERAPEUTICS CORP. (KTTA) reported Disposal Group, Including Discontinued Operation, General and Administrative Expense of $518.96 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense · last filed 2025-03-24
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2023-12-31 was $16.89K, a 98.68% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2023-06-30 was $165.15K, a 64.64% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2023-03-31 was $271.87K.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, general and administrative expense for fiscal 2023 was $518.96K, a 80.05% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, general and administrative expense for fiscal 2022 was $2.60M.
| Period end | Disposal Group, Including Discontinued Operation, General and Administrative Expense 3 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 6 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 9 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $16.89K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $16.89K derived: sum of 2 quarters · filed 2025-03-24 | $182.04K derived: sum of 3 quarters · filed 2025-03-24 | $518.96K 10-K · filed 2025-03-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $165.15K derived: sum of 2 quarters · filed 2024-11-13 | $502.06K 10-Q · filed 2024-11-13 | $1.72M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $165.15K 10-Q · filed 2024-08-13 | $502.06K 10-Q · filed 2024-08-13 | $1.72M derived: sum of 3 quarters · filed 2024-08-13 | $2.24M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $271.87K 10-Q · filed 2024-05-14 | $1.55M derived: sum of 2 quarters · filed 2024-05-14 | $2.08M derived: sum of 3 quarters · filed 2024-05-14 | $2.55M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.81M derived: sum of 2 quarters · filed 2024-03-29 | $2.27M derived: sum of 3 quarters · filed 2024-03-29 | $2.60M 10-K · filed 2024-03-29 |
| 2022-09-30 | $527.23K 10-Q · filed 2023-11-13 | $994.25K derived: sum of 2 quarters · filed 2023-11-13 | $1.32M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $467.02K 10-Q · filed 2023-08-11 | $793.39K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |